The use of berberine in the treatment of diabetes: The available evidence and expert opinion
Keywords:
Diabetic supplements, berberine, expert opinion.Abstract
Nutritional supplements have been increasingly used in the prevention and treatment of a variety of chronic disorders including diabetes. Research evidence has been increasing suggesting the usefulness of several supplements including fenugreek, cinnamon, and lipoic acid in the management of diabetes.During the previous decades, berberines, a plant alkaloid that can be obtained from Rhizoma Coptidis and Coptis Chinensis Franch have been reported mostly by Chinese researchers to have beneficial effects in diabetes. This paper reviews the available evidence supporting the use of berberine in diabetes with the aim of providing expert opinion.Expert opinion: The available evidence suggests that berberine has anti-diabetic effects through improving insulin secretion and it can also improves lipids profile. Berberine has been reported to have pancreatic β-cells protective and can increase peripheral tissues insulin sensitivity. It can also stimulate glycolysis, and thus it can improve insulin resistance. In addition, it can inhibit intestinal α-glucosidase and reducing absorption of glucose decrease. However, the available evidence research also suggests the usefulness of several other supplements including fenugreek, cinnamon, and lipoic acid in the management of diabetes. Therefore, the choice of diabetic supplement depends to some extent on the availability and cost. It seems that berberine is the most available and cost effective diabetic supplement in China, however, it is not in other counties in the world including Iraq.
Downloads
References
-Al-Mosawi AJ. The Use of Fenugreek Supplementation in Diabetes. Scientific Research Journal of Clinical and Medical Sciences (p-ISSN: 2788-8843, e-ISSN: 2788-8 851) 2021; 1(1): 9-13. Doi: 10.5281/zenodo.5170255.
-Al-Mosawi AJ. The use of cinnamon supplementation in diabetes: Research evidence and expert opinion. Journal of Clinical Trails and Bioavailability Research (e-ISSN: 2836-5836) 2022; 1(1): 1-4. Doi: 10.584 89/JCTBR.004.
-Al-Mosawi AJ. The use of alpha-lipoic acid supplementation in diabetes: The available Evidence. Journal of Clinical Trails and Bioavailability Research (e-ISSN: 2836-5836). Dec 28, 2022; 1(1): 1-6. Doi: 10.58489/JCTBR.003.
-Chen QM, Xie MZ. [Studies on the hypoglycemic effect of Coptis chinensis and berberine]. Yao Xue Xue Bao 1986 Jun; 21(6):401-6 [Article in Chinese].
-Ni YX. [Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research]. Zhong Xi Yi Jie He Za Zhi 1988 Dec; 8(12):711-3, 707 [Article in Chinese].
-Zhou LB, Chen MD, Wang X, Song HD, Yang Y, Tang JF, Li FY, Xu MY, Chen JL. [Effect of berberine on the differentiation of adipocyte]. Zhonghua Yi Xue Za Zhi. 2003 Feb 25; 83(4):338-40 [Article in Chinese].
-Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 2004 Apr; 25(4):496-502.
-Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008 May; 57(5):712-7. Doi: 10.1016/j.metabol.2008.01.013.
-Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, Huo L, Wang M, Hong J, Wu P, Ren G, Ning G. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 2008 Jul; 93(7):2559-65. Doi: 10.1210/jc.2007-2404.
-Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol 2015 Feb 23; 161:69-81. Doi: 10.1016/j.jep.2014.09.049.
-Li ZY, Liu B, Zhuang XJ, Shen YD, Tian HR, Ji Y, Li LX, Liu F. [Effects of berberine on the serum cystatin C levels and urine albumin/creatine ratio in patients with type 2 diabetes mellitus]. Zhonghua Yi Xue Za Zhi 2018 Dec 11; 98(46):3756-3761. Doi: 10.3760/cma.j.issn.0376-2491.2018.46.007 [Article in Chinese].
-Liang Y, Xu X, Yin M, Zhang Y, Huang L, Chen R, Ni J. Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. Endocr J 2019 Jan 28; 66(1):51-63. Doi: 10.1507/endocrj.EJ18-0109.
-Guo J, Chen H, Zhang X, Lou W, Zhang P, Qiu Y, Zhang C, Wang Y, Liu WJ. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev 2021 Dec 15; 2021:2074610. Doi: 10.1155/2021/2074610.
-Hu S, Wang J, Liu E, Zhang X, Xiang J, Li W, Wei P, Zeng J, Zhang Y, Ma X. Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action. Pharmacol Res 2022 Nov; 185:106481. Doi: 10.1016/j.phrs.2022.106481.
-Panigrahi A, Mohanty S. Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial. BMC Endocr Disord 2023 Sep 7; 23(1):190. Doi: 10.1186/s12902-023-01442-y.

Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Current Clinical and Medical Education